Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia

Marilyn L. Slovak, Kenneth J. Kopecky, Peter A. Cassileth, David H. Harrington, Karl S. Theil, Anwar Mohamed, Elizabeth Paietta, Cheryl L. Willman, David R. Head, Jacob M. Rowe, Stephen J. Forman, Frederick R. Appelbaum, Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study Blood. ,vol. 96, pp. 4075- 4083 ,(2000) , 10.1182/BLOOD.V96.13.4075

David Grimwade, Helen Walker, Fiona Oliver, Keith Wheatley, Christine Harrison, Georgina Harrison, John Rees, Ian Hann, Richard Stevens, Alan Burnett, Anthony Goldstone, The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial Blood. ,vol. 92, pp. 2322- 2333 ,(1998) , 10.1182/BLOOD.V92.7.2322

Satoru Tanabe, Nancy J. Zeleznik-Le, Hirofumi Kobayashi, Christine Vignon, Rafael Espinosa, Michelle M. LeBeau, Michael J. Thirman, Janet D. Rowley, Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML-2 cell line. Genes, Chromosomes and Cancer. ,vol. 15, pp. 206- 216 ,(1996) , 10.1002/(SICI)1098-2264(199604)15:4<206::AID-GCC2>3.0.CO;2-5

Andreas Rosenwald, George Wright, Wing C. Chan, Joseph M. Connors, Elias Campo, Richard I. Fisher, Randy D. Gascoyne, H. Konrad Muller-Hermelink, Erlend B. Smeland, Jena M. Giltnane, Elaine M. Hurt, Hong Zhao, Lauren Averett, Liming Yang, Wyndham H. Wilson, Elaine S. Jaffe, Richard Simon, Richard D. Klausner, John Powell, Patricia L. Duffey, Dan L. Longo, Timothy C. Greiner, Dennis D. Weisenburger, Warren G. Sanger, Bhavana J. Dave, James C. Lynch, Julie Vose, James O. Armitage, Emilio Montserrat, Armando López-Guillermo, Thomas M. Grogan, Thomas P. Miller, Michel LeBlanc, German Ott, Stein Kvaloy, Jan Delabie, Harald Holte, Peter Krajci, Trond Stokke, Louis M. Staudt, The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma The New England Journal of Medicine. ,vol. 346, pp. 1937- 1947 ,(2002) , 10.1056/NEJMOA012914

Carlos M. Galmarini, Xavier Thomas, Fabien Calvo, Philippe Rousselot, Muriel Rabilloud, Assia El Jaffari, Emeline Cros, Charles Dumontet, In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia British Journal of Haematology. ,vol. 117, pp. 860- 868 ,(2002) , 10.1046/J.1365-2141.2002.03538.X

Gunter Schuch, Marcelle Machluf, Georg Bartsch, Masashi Nomi, Henri Richard, Anthony Atala, Shay Soker, In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo Blood. ,vol. 100, pp. 4622- 4628 ,(2002) , 10.1182/BLOOD.V100.13.4622

David G. Beer, Sharon L.R. Kardia, Chiang-Ching Huang, Thomas J. Giordano, Albert M. Levin, David E. Misek, Lin Lin, Guoan Chen, Tarek G. Gharib, Dafydd G. Thomas, Michelle L. Lizyness, Rork Kuick, Satoru Hayasaka, Jeremy M.G. Taylor, Mark D. Iannettoni, Mark B. Orringer, Samir Hanash, Gene-expression profiles predict survival of patients with lung adenocarcinoma Nature Medicine. ,vol. 8, pp. 816- 824 ,(2002) , 10.1038/NM733

Hans-Peter Gerber, Ajay K Malik, Gregg P Solar, Daniel Sherman, Xiao Huan Liang, Gloria Meng, Kyu Hong, James C Marsters, Napoleone Ferrara, None, VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism Nature. ,vol. 417, pp. 954- 958 ,(2002) , 10.1038/NATURE00821

Keiki Kumano, Shigeru Chiba, Kiyoshi Shimizu, Tetsuya Yamagata, Noriko Hosoya, Toshiki Saito, Tokiharu Takahashi, Yoshio Hamada, Hisamaru Hirai, Notch1 inhibits differentiation of hematopoietic cells by sustaining GATA-2 expression Blood. ,vol. 98, pp. 3283- 3289 ,(2001) , 10.1182/BLOOD.V98.12.3283

Chi Wai So, Michael L. Cleary, Common mechanism for oncogenic activation of MLL by forkhead family proteins Blood. ,vol. 101, pp. 633- 639 ,(2003) , 10.1182/BLOOD-2002-06-1785